BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10652634)

  • 1. Oncoprotein coexpression in human aberrant crypt foci and minute polypoid lesions of the large bowel.
    Shpitz B; Bomstein Y; Shalev M; Liverant S; Kaufman Z; Klein E; Mekori Y; Bernheim J
    Anticancer Res; 1999; 19(4B):3361-6. PubMed ID: 10652634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
    Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
    Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis.
    Subramaniam MM; Chan JY; Soong R; Ito K; Yeoh KG; Wong R; Guenther T; Will O; Chen CL; Kumarasinghe MP; Ito Y; Salto-Tellez M
    Am J Gastroenterol; 2009 Feb; 104(2):426-36. PubMed ID: 19174785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic switch in earliest stages of human colonic tumorigenesis.
    Shpitz B; Gochberg S; Neufeld D; Grankin M; Buklan G; Klein E; Bernheim J
    Anticancer Res; 2003; 23(6D):5153-7. PubMed ID: 14981982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin expression is altered in human colonic aberrant crypt foci.
    Hao XP; Pretlow TG; Rao JS; Pretlow TP
    Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant crypt focus size predicts distal polyp histopathology.
    Kim J; Ng J; Arozulllah A; Ewing R; Llor X; Carroll RE; Benya RV
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1155-62. PubMed ID: 18483337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
    Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations in chronic ulcerative colitis-associated and sporadic hyperplastic polyps: a comparative analysis.
    Odze RD; Brien T; Brown CA; Hartman CJ; Wellman A; Fogt F
    Am J Gastroenterol; 2002 May; 97(5):1235-42. PubMed ID: 12014733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
    Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colorectal cancer.
    Niitsu Y; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Abe T; Kogawa T; Takahashi M; Matsunaga T; Kato J
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S40-3. PubMed ID: 15309513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of decorin expression in polyps and carcinomas of the colon.
    Augoff K; Rabczynski J; Tabola R; Czapla L; Ratajczak K; Grabowski K
    Med Sci Monit; 2008 Oct; 14(10):CR530-5. PubMed ID: 18830193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of aberrant crypt foci.
    Schoen RE; Mutch M; Rall C; Dry SM; Seligson D; Umar A; Pinsky P
    Gastrointest Endosc; 2008 Jun; 67(7):1097-102. PubMed ID: 18178205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic changes in aberrant crypt foci and serrated polyps.
    Suehiro Y; Hinoda Y
    Cancer Sci; 2008 Jun; 99(6):1071-6. PubMed ID: 18384435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of monoclonality in human aberrant crypt foci.
    Siu IM; Robinson DR; Schwartz S; Kung HJ; Pretlow TG; Petersen RB; Pretlow TP
    Cancer Res; 1999 Jan; 59(1):63-6. PubMed ID: 9892186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon.
    Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Grankin M; Bernheim J
    Am J Surg; 1997 Oct; 174(4):425-30. PubMed ID: 9337168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell turnover of serrated adenomas.
    Ladas SD; Kitsanta P; Triantafyllou K; Tzathas C; Spiliadi C; Raptis SA
    J Pathol; 2005 May; 206(1):62-7. PubMed ID: 15751053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant crypt foci in colon cancer epidemiology.
    Khare S; Chaudhary K; Bissonnette M; Carroll R
    Methods Mol Biol; 2009; 472():373-86. PubMed ID: 19107443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.